Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are currently used in vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019…
Read More
CN Bio introduces the PhysioMimix™ OOC Multi-Organ Microphysiological System
CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), otherwise known as organ-on-a-chip (OOC), today announced the commercial launch of its new PhysioMimix™ OOC Multi-Organ MPS. The next-generation platform combines CN Bio’s in vitro 3D liver model,…
Read More
Xenograft model for invasive lobular carcinoma simulates tumor with high accuracy
Invasive lobular carcinoma (ILC) is a type of breast cancer that begins in the milk-producing glands (lobules) of the breast. It covers 10-15% of all breast cancer cases, has a high risk of late recurrence, unique metastatic sites, high sensitivity…
Read More
In Vitro vs In Vivo Preclinical Studies
Before a drug candidate can be tested in humans, its safety and efficacy must be explored in preclinical studies. These studies can either be ‘in vitro’, Latin for “within the glass” and referring to studies using cell cultures studied outside…
Read More
Novel hybrid device to boost research on metastatic process of breast cancer cells
European researchers are working on a novel hybrid device to better understand the metastatic process of cancer cells traveling from breast to bone and fast screen new drugs against it. The spread of cancer cells to other parts of the…
Read More
What is SATI Gene Editing?
Skip to: The Process Application of SATI in a Mouse-model Progeria Study The Future of Gene Editing? One strategy for studying and understanding biological processes and inherited conditions is gene splicing. The technology lies at the cutting-edge of research into…
Read More